Targeting ferroptosis to treat high-risk neuroblastoma
Inducing iron-dependent death to treat high-risk childhood cancer Neuroblastoma (NB) is the most common pediatric extracranial solid tumor and one of the deadliest, accounting for 15% of pediatric cancer deaths. In Europe there are 10.5 cases per million, with the median age at diagnosis being 17 months. In some cases, tumors regress spontaneously but in others they relapse and become resistant t